BioCryst Pharmaceuticals Revenue 2006-2019 | BCRX

BioCryst Pharmaceuticals revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
BioCryst Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $21
2017 $25
2016 $26
2015 $48
2014 $14
2013 $17
2012 $26
2011 $20
2010 $62
2009 $75
2008 $57
2007 $71
2006 $6
2005 $0
BioCryst Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $2
Q2 2019 $1
Q1 2019 $6
Q4 2018 $3
Q3 2018 $1
Q2 2018 $12
Q1 2018 $4
Q4 2017 $4
Q3 2017 $9
Q2 2017 $3
Q1 2017 $9
Q4 2016 $9
Q3 2016 $8
Q2 2016 $5
Q1 2016 $5
Q4 2015 $5
Q3 2015 $11
Q2 2015 $26
Q1 2015 $7
Q4 2014 $5
Q3 2014 $3
Q2 2014 $1
Q1 2014 $3
Q4 2013 $11
Q3 2013 $2
Q2 2013 $1
Q1 2013 $4
Q4 2012 $4
Q3 2012 $6
Q2 2012 $4
Q1 2012 $12
Q4 2011 $5
Q3 2011 $5
Q2 2011 $4
Q1 2011 $5
Q4 2010 $17
Q3 2010 $12
Q2 2010 $8
Q1 2010 $26
Q4 2009 $55
Q3 2009 $11
Q2 2009 $5
Q1 2009 $4
Q4 2008 $34
Q3 2008 $9
Q2 2008 $3
Q1 2008 $11
Q4 2007 $28
Q3 2007 $20
Q2 2007 $13
Q1 2007 $9
Q4 2006 $2
Q3 2006 $2
Q2 2006 $2
Q1 2006 $1
Q4 2005 $0
Q3 2005 $0
Q2 2005 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.417B $0.021B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.419B 39.58
Takeda Pharmaceutical (TAK) Japan $59.257B 10.50
Astellas Pharma (ALPMY) Japan $32.450B 16.21
Eisai (ESALY) Japan $23.257B 44.83
Grifols, S.A (GRFS) Spain $17.395B 22.79
Merck (MKGAF) Germany $17.280B 23.58
Neurocrine Biosciences (NBIX) United States $9.617B 267.18
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.880B 36.54
Ionis Pharmaceuticals (IONS) United States $8.683B 17.59
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.786B 9.94
IPSEN SA ADR (IPSEY) France $6.078B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.263B 16.01
United Therapeutics (UTHR) United States $4.692B 0.00
Evotec AG (EVTCY) Germany $4.257B 68.69
Arrowhead Pharmaceuticals (ARWR) United States $4.059B 75.34
Nektar Therapeutics (NKTR) United States $4.018B 0.00
FibroGen (FGEN) United States $3.987B 117.18
PTC Therapeutics (PTCT) United States $3.658B 0.00
Sage Therapeutics (SAGE) United States $3.577B 0.00
ChemoCentryx (CCXI) United States $2.933B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.774B 11.22
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.239B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.116B 62.59
Xencor (XNCR) United States $2.007B 61.00
Heron Therapeutics (HRTX) United States $1.951B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.870B 22.93
Tilray (TLRY) Canada $1.860B 0.00
Corcept Therapeutics (CORT) United States $1.582B 19.22
USANA Health Sciences (USNA) United States $1.545B 16.15
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.463B 9.98
Theravance Biopharma (TBPH) Cayman Islands $1.436B 0.00
Endo (ENDP) Ireland $1.420B 2.61
Zogenix (ZGNX) United States $1.347B 0.00
Akebia Therapeutics (AKBA) United States $1.153B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.063B 32.93
Portola Pharmaceuticals (PTLA) United States $1.057B 0.00
Karyopharm Therapeutics (KPTI) United States $1.025B 0.00
Dermira (DERM) United States $1.022B 0.00
Radius Health (RDUS) United States $0.918B 0.00
Aerie Pharmaceuticals (AERI) United States $0.902B 0.00
ImmunoGen (IMGN) United States $0.853B 0.00
Collegium Pharmaceutical (COLL) United States $0.801B 0.00
TherapeuticsMD (TXMD) United States $0.651B 0.00
Flexion Therapeutics (FLXN) United States $0.621B 0.00
Molecular Templates (MTEM) United States $0.576B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.547B 0.00
Ardelyx (ARDX) United States $0.545B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.530B 64.25
Translate Bio (TBIO) United States $0.481B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.475B 20.47
Organogenesis Holdings (ORGO) United States $0.465B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.455B 0.00
Innate Pharma SA (IPHYF) France $0.446B 0.00
Calithera Biosciences (CALA) United States $0.419B 0.00
Siga Technologies (SIGA) United States $0.405B 9.26
DURECT (DRRX) United States $0.396B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.387B 0.00
Recro Pharma (REPH) United States $0.385B 0.00
Lannett Co Inc (LCI) United States $0.374B 6.03
Harpoon Therapeutics (HARP) United States $0.370B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.369B 0.00
Indivior (INVVY) United States $0.359B 2.13
Concert Pharmaceuticals (CNCE) United States $0.346B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.324B 0.00
Rafael Holdings (RFL) United States $0.324B 0.00
OptiNose (OPTN) United States $0.316B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.296B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.267B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.262B 0.00
KalVista Pharmaceuticals (KALV) United States $0.259B 0.00
Ocular Therapeutix (OCUL) United States $0.254B 0.00
MEI Pharma (MEIP) United States $0.249B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.226B 0.00
IMV INC (IMV) Canada $0.223B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.210B 0.00
Nature's Sunshine Products (NATR) United States $0.198B 34.10
Jounce Therapeutics (JNCE) United States $0.195B 2.60
Taiwan Liposome (TLC) Taiwan $0.192B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
Xeris Pharmaceuticals (XERS) United States $0.127B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.123B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.119B 0.00
CannTrust Holdings (CTST) Canada $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Otonomy (OTIC) United States $0.113B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.111B 0.00
Redhill Biopharma (RDHL) Israel $0.110B 0.00
Aquestive Therapeutics (AQST) United States $0.107B 0.00
CV Sciences (CVSI) United States $0.085B 0.00
Champions Oncology (CSBR) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
Onconova Therapeutics (ONTX) United States $0.074B 0.00
CTI BioPharma (CTIC) United States $0.072B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 20.32
SCYNEXIS (SCYX) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Nivalis Therapeutics (ALPN) United States $0.062B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
IsoRay (ISR) United States $0.058B 0.00
Aclaris Therapeutics (ACRS) United States $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
Natural Alternatives (NAII) United States $0.051B 23.28
Forward Pharma (FWP) Denmark $0.050B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.050B 0.00
VAXART, INC (VXRT) United States $0.050B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
PolarityTE (PTE) United States $0.044B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
Biomerica (BMRA) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Vical (BBI) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cardiome Pharma (CORV) Canada $0.016B 0.00
Shineco (TYHT) China $0.015B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Novan (NOVN) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00